Please ensure Javascript is enabled for purposes of website accessibility

U.S. Health Official Warns: COVID-19 Will Hit the United States

By Taylor Carmichael - Feb 25, 2020 at 3:16PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Americans should prepare for the possibility that their lives will be disrupted due to the pandemic, says the CDC's Nancy Messonnier.

Officials from the Centers for Disease Control and Prevention (CDC) spoke with reporters on Tuesday about the escalating viral outbreak that started in Wuhan, China. "We are asking the American public to prepare for the expectation that this might be bad," a CDC official said. 

Nancy Messonnier, the director of the CDC's National Center for Immunization and Respiratory Diseases, said "We really want to prepare the American public for the possibility that their lives will be disrupted because of this pandemic." She added that COVID-19 will definitely spread to the United States. "It's not a question of if this will happen but when this will happen and how many people in this country will have severe illnesses." 

There have been 80,238 confirmed cases of COVID-19 in 34 countries so far, and it has caused at least 2,700 deaths, according to World Health Organization (WHO). The number of case is soaring in South Korea -- 977 people have been confirmed to have the disease, and 10 deaths have been reported.

Covid-19 blood sample

Image source: Getty Images

The race for a vaccine

Shares of Moderna (MRNA 3.27%) shot up 19% on Tuesday after the company announced that its experimental vaccine for the coronavirus, mRNA-1273, had been shipped to researchers at the National Institute of Allergy and Infectious Diseases (NIAID). The company estimates that the first clinical trial will start in April, with results by August. 

A WHO official in China reported Monday that there are signs that a drug from Gilead Sciences (GILD 5.16%), remdesivir, might successfully treat people with COVID-19. "There is only one drug right now that we think may have real efficacy and that's remdesivir," Bruce Aylward said at a press conference in Beijing.

Taylor Carmichael has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Gilead Sciences. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Gilead Sciences, Inc. Stock Quote
Gilead Sciences, Inc.
GILD
$66.21 (5.16%) $3.25
Moderna, Inc. Stock Quote
Moderna, Inc.
MRNA
$176.78 (3.27%) $5.60

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/15/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.